Last deal

Amount

Seed

Stage

01.01.1985

Date

1

all rounds

date founded

Financing round

General

About Company
Sunovion is a global biopharmaceutical company.

Industry

Sector :

Subsector :

Also Known As

Sepracor

founded date

01.01.1984

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Sunovion is a biopharmaceutical company that focuses on developing life-transforming treatments for psychiatric, neurological, and respiratory conditions. They have a track record of discovering, developing, and commercializing important therapies, including medications for schizophrenia, epilepsy, and respiratory disorders.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Conatus Pharmaceuticals

Conatus Pharmaceuticals

Conatus Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative medicines to treat chronic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

San Diego, CA, USA

total rounds

6

total raised

$62.1M
Intercept Pharmaceuticals

Intercept Pharmaceuticals

Intercept Pharmaceuticals develops and sells treatments for liver diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

New York, NY, USA

total rounds

8

total raised

$567.12M
Adastra Pharmaceuticals

Adastra Pharmaceuticals

Adastra Pharmaceuticals is a clinical-stage oncology company that develops proprietary medicines for the treatment of various cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

10

total raised

$85M

count Of Investments

1
Biohaven

Biohaven

Biohaven is a biopharmaceutical firm focused on unearthing and creating treatments for severe illnesses.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New Haven, CT, USA

total rounds

2

total raised

$455M
M&A Details
1

Acquired by

Dainippon Sumitomo Pharma

announced date

03.09.2009

price

$2.6B

Financials

Funding Rounds
1
1

Number of Funding Rounds

Their latest funding was raised on 01.01.1985. Their latest investor Venrock. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.1985
1
Co-Investors
Investors
1
0

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
No
Seed
Venrock

Venrock

Venrock partners with entrepreneurs to build disruptive, successful companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services

Location

Palo Alto, CA, USA

count Of Investments

619

count Of Exists

216
Acquisitions
2
Cynapsus Therapeutics acquired by Sunovion Pharmaceuticals

Cynapsus Therapeutics acquired by Sunovion Pharmaceuticals

acquirer

Sunovion Pharmaceuticals
Sunovion Pharmaceuticals

date

31.08.2016

type

Acquisition

price

$624M
Cynapsus Therapeutics

Cynapsus Therapeutics

Cynapsus is a pharmaceutical company developing a non-injectable drug for Parkinson's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Biotechnology, Health Care

Location

Toronto, ON, Canada

total rounds

6

total raised

$56.68M
Elevation Pharmaceuticals acquired by Sunovion Pharmaceuticals

Elevation Pharmaceuticals acquired by Sunovion Pharmaceuticals

acquirer

Sunovion Pharmaceuticals
Sunovion Pharmaceuticals

date

30.08.2012

type

Acquisition

price

$430M
Elevation Pharmaceuticals

Elevation Pharmaceuticals

Elevation Pharmaceuticals develops improved aerosol drug products for COPD patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

4

total raised

$89.4M

People

Founders
1
Timothy J. Barberich
Timothy J. Barberich

Timothy J. Barberich

Tim Barberich is the Director at Newcastle Holdings.

current job

Newcastle Holdings

count Of Investments

1

count Of Exists

1

Timothy J. Barberich

Employee Profiles
727

Art Thomas

Senior director commercial analytics business partner

Judine Thomas

Director salesforce optimization and planning

Patrick Gaffey

Vice president corporate communications

Melinda Berry

Senior l and od performance consultant

Reilly Decker

Executive director, marketing

Marcy Thoman

Executive assistant to the chief financial officer of sunovion

Carrie Spear

Supply chain manager

Aditi Kadakia

Associate director, health economics and outcomes research

Activity

Recent News
1